Should you buy these healthcare shares?

Should you buy CSL Limited (ASX:CSL) shares and two others in the healthcare sector?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performing areas of the share market over the last 12 months has been the healthcare sector.

During this time the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) has managed to put on a gain of almost 27%.

While I wouldn't necessarily expect the sector to replicate this gain over the next 12 months, thanks to Australia's ageing population and increasing chronic disease burden I still believe it could continue to outperform the rest of the market.

With that in mind, should you buy these three healthcare shares?

CSL Limited (ASX: CSL)

The strong performance of this biotherapeutics company's shares over the last 12 months have played a key role in taking the S&P/ASX 200 Health Care index higher. While this leaves its shares close to an all-time high, I don't think it is too late to invest if you're prepared to hold them for the long-term. However, if you're more focused on the short term you might want to wait in hope of a pullback in its share price before investing.

Nanosonics Ltd (ASX: NAN)

I'm a big fan of this infection control specialist and believe it could have a very bright future ahead of it. Especially given its plan to release complementary products in the near future that will both boost and diversify its revenue. One thing of note, though, is that the company is currently being targeted by short sellers and is one of the most shorted shares on the Australian share market. It is unclear why short sellers have taken an interest, which does leave me concerned that they know something that I don't. Because of this, I'm staying clear of Nanosonics until short interest fades.

Ramsay Health Care Limited (ASX: RHC)

Ramsay Health Care is one of the world's leading private hospital operators. Whilst I am a huge fan of Ramsay and would love to have it in my portfolio, I'm keeping away from the company until its shares are trading at a level more befitting of its current growth profile. At present Ramsay's growth is being held back by weakness in Europe and falling private hospital coverage here in Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »